PO.TB10.05 · 肿瘤生物学
宿主年龄对早发或晚发西班牙裔结直肠癌患者来源肿瘤表观遗传学的影响
Age of host impact on epigenetics in tumors derived from early or late onset Hispanic colorectal cancer patients
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言 在过去十年中,与晚发型(LO)结直肠癌(CRC)相比,50岁以下成人的早发型(EO)CRC发病率显著上升,在西班牙裔/拉丁裔(H&L)人群中尤为明显。EO CRC与LO CRC相比表现出独特的分子特征,使这一独特疾病呈现更具侵袭性的表现。研究年龄在肿瘤和宿主环境中的影响,可能有助于揭示EO与LO CRC之间的关键差异。本研究作为癌症登月计划(Cancer Moonshot Program)的一部分,探讨宿主年龄如何影响CRC肿瘤中的表观遗传学变化。
方法 将来自一名36岁EO患者(年轻患者,YP)和一名66岁LO患者(老年患者,OP)的H&L男性CRC患者来源肿瘤样本,分别植入年轻(2月龄,YM)和年老的雄性NSG小鼠(13-14月龄,OM),建立四种PDX模型:YM中的YP、YM中的OP、OM中的YP和OM中的OP。在终点(长度或宽度达15mm)采集肿瘤样本。使用Illumina EPIC Array表观遗传学试剂盒对肿瘤进行表观基因组分析。利用甲基化数据鉴定OM中的YP相较于YM中的YP、以及YM中的OP相较于OM中的OP的差异甲基化区域(Δbeta>0.1)。将鉴定出的区域使用UCSC的人类基因组(GRCh38基因组参考联盟人类参考序列38)映射到最近的基因。将差异甲基化基因(Δbeta>0.2)输入Ingenuity Pathway Analysis以鉴定相关的生物学通路。
结果 与YM中的YP相比,OM中的YP共鉴定出8916个差异甲基化区域。其中5529个区域呈高甲基化,3387个呈低甲基化。这些区域映射到5886个独特的基因符号,其中1061个高甲基化,999个低甲基化。OM中的YP显示出关键基因的预测激活,包括参与胃肠道癌症发生和进展的TNF、WNT1、MYB、ERBB3、GLI3、EGR2和EGR3。与OM中的OP相比,YM中的OP共鉴定出28032个差异甲基化区域(Δbeta>0.1)。其中17590个区域呈高甲基化,10442个呈低甲基化。这些区域映射到11888个独特的基因符号,其中4273个高甲基化,2936个低甲基化。YM中的OP显示出关键基因的预测抑制,包括参与细胞转化和肿瘤细胞转移的RELA、TNF、EGFR、YAP1、WNT3A、FGF2、IFNG、SP1、IGF1、ERBB2和TEAD1。
结论 我们目前的研究结果显示了EO与LO CRC PDX模型在表观遗传DNA甲基化模式上的差异。EO和LO CRC中的差异甲基化区域分析表明,无论肿瘤年龄如何,较大的宿主年龄可能与癌症相关基因的激活相关,而较小的宿主年龄可能抑制相似的通路。有必要进行进一步研究,以理解影响所观察到差异的表观遗传学修饰。
查看英文原文 English abstract
Introduction Over the past decade, the incidence of early-onset (EO) colorectal cancer (CRC) in adults under 50 has shown a significant increase compared to late-onset (LO) CRC rates, especially in the Hispanic/Latino (H&L) population. EO CRC exhibits unique molecular features compared to LO CRC, associating this distinct disease with a more aggressive presentation. Investigations on the effect of age within both the tumor and host environments could provide insight into key differences between EO and LO CRCs. This study, as part of Cancer Moonshot Program, explores how age of the host influences epigenetic changes in CRC tumors.
Methods CRC patient derived tumor samples from an EO 36 year old (young patient, YP) and a LO 66 year old (old patient, OP) H&L male were implanted into both young (2 months, YM) and old male NSG mice (13-14 months, OM) to establish four PDX models: YP in YM, OP in YM, YP in OM, and OP in OM. Tumor samples were collected at endpoint (15mm length or width). Tumors were processed for epigenomic analysis using the Illumina EPIC Array Epigenetics Kit. Methylation data was used to identify differentially methylated regions (Δbeta>0.1) in YP in OM compared to YP in YM and OP in YM compared to OP in OM. Identified regions were mapped to the nearest gene using the human genome (GRCh38 Genome Reference Consortium Human Reference 38) from UCSC. The differentially methylated genes (Δbeta>0.2) were input into Ingenuity Pathway Analysis to identify relevant biological pathways.
Results There were 8916 differentially methylated regions identified in YP in OM when compared to YP in YM. Of these regions, 5529 showed hypermethylation and 3387 showed hypomethylation. Regions were mapped to 5886 unique gene symbols, of which 1061 were hypermethylated and 999 were hypomethylated. YP in OM showed predicted activation of key genes, including TNF, WNT1, MYB, ERBB3, GLI3, EGR2, and EGR3, involved in the development and progression of gastrointestinal cancers. There were 28032 differentially methylated regions (Δbeta>0.1) identified in OP in YM when compared to OP in OM. If these regions, 17590 showed hypermethylation and 10442 showed hypomethylation. Regions were mapped to 11888 unique gene symbols, of which 4273 were hypermethylated and 2936 were hypomethylated. OP in YM showed predicted inhibition of key genes, including RELA, TNF, EGFR, YAP1, WNT3A, FGF2, IFNG, SP1, IGF1, ERBB2 and TEAD1, involved in cell transformation and tumor cell metastasis.
Conclusions Our current findings show differences in epigenetic DNA methylation patterns in EO and LO CRC PDX models. Differentially methylated region analysis in both EO and LO CRC suggests that an older host age may correlate with activation of cancer related genes while younger host age may inhibit similar pathways, regardless of tumor age. Further studies are warranted to understand the epigenetics modifications that influence the observed differences.
利益披露 Disclosure
L. Torres-Gonzalez, None..
S. Soni, None..
Z. Yang, None..
B. Y. Tew, None..
J. H. Lo, None..
P. Mittal, None..
U. H. Shah, None..
M. Bartolini, None..
S. Soto Trujillo, None..
Y. Goretsky, None..
S. Algaze, None..
W. Zhang, None..
S. Bodour, None..
H. Lenz, None.